Resources for Journalists

COVID-19 is a disease caused by the SARS-CoV-2 virus strain, that has not been previously identified in humans. See below for a collection of resources to help you cover this issue (Please note: additional resources are available to journalists who are logged in).

The AusSMC also issues a daily COVID-19 update for registered journalists (click here to view an example). If you would like to receive this email, please go to your profile on MyScimex and select yes beside "Receive COVID-19 Updates?". The email update and this resources page are supported by the Google News Initiative.

Latest COVID-19 news, research, expert reactions and briefings

Show/Hide newsfeed filter Filter by
Type
News for

Choose a location of interest

  1. What household cleaning products can inactivate SARS-CoV-2?

    Publicly released: Tue 12 Apr 2022 at 1500 AEST, 1700 NZST

    Viruses

    While vaccinations are key to preventing severe disease and hospitalisation caused by SARS-CoV-2 infection, the virus can still infect vaccinated individuals. ... over the potential SARS-CoV-2 Read more about What household cleaning products can inactivate SARS-CoV-2?

    Australia; VICThe Peter Doherty Institute for Infection and Immunity ...

  2. Risk of heart inflammation from COVID-19 vax lower than from Influenza vax

    Publicly released: Tue 12 Apr 2022 at 0830 AEST, 1030 NZST

    The Lancet Respiratory Medicine

    The researchers examined international databases, looking at more than 400 million vaccination doses, to compare the risk of myopericarditis following vaccination against COVID-19 and other diseases Read more about Risk of heart inflammation from COVID-19 vax lower than from Influenza vax

    InternationalNational University Hospital, Singapore

  3. Are you physically less likely to become infected with COVID-19?

    Publicly released: Tue 12 Apr 2022 at 0100 AEST, 0300 NZST

    Nature Genetics

    The team also defined three new, protective phenotypes related to the risk of infection following household exposure to SARS-CoV-2 and to symptom severity. ... These newly-identified phenotypes are Read more about Are you physically less likely to become infected with COVID-19?

    InternationalAncestryDNA, USA

  4. Reducing crisis risk in tourism, hospitality

    Publicly released: Mon 11 Apr 2022 at 1200 AEST, 1400 NZST

    Tourism Review International

    With international travel conditions still volatile, the researchers recommend further measures be taken to protect tourism and hospitality businesses while maintaining high levels of trust and Read more about Reducing crisis risk in tourism, hospitality

    Australia; New Zealand; VIC; SAFlinders University | University of Canterbury

  5. How frequently do vaccinated cancer patients catch COVID-19?

    Publicly released: Sat 9 Apr 2022 at 0100 AEST, 0300 NZST

    JAMA Oncology

    People undergoing cancer treatment are at higher risk of breakthrough COVID-19 infection (getting the virus despite being vaccinated) according to international research. ... The team used US electronic Read more about How frequently do vaccinated cancer patients catch COVID-19?

    InternationalCase Western Reserve University, USA

  6. Vaccine-related blood clots could be the result of genetics

    Publicly released: Fri 8 Apr 2022 at 1102 AEST, 1302 NZST

    medRxiv

    Vaccine-induced thrombotic thrombocytopenia (VITT), a rare disorder causing thrombosis (blood clotting) and thrombocytopenia (low blood platelet counts), was early in 2021 linked to the AstraZeneca Read more about Vaccine-related blood clots could be the result of genetics

    Australia; SAFlinders University | SA Pathology

  7. Did the 4-month COVID-19 lockdown affect Victorians long-term?

    Publicly released: Fri 8 Apr 2022 at 1100 AEST, 1300 NZST

    PLOS ONE

    Victoria's four-month COVID-19 lockdown in 2020 negatively affected the mental health of the state's residents, according to Aussie researchers, who say this impact was not permanent, and ... The team Read more about Did the 4-month COVID-19 lockdown affect Victorians long-term?

    Australia; VIC; ACTMonash University | The Australian National University

  8. Could a sniff test using smelly stuff at home pick up COVID-19?

    Publicly released: Fri 8 Apr 2022 at 0900 AEST, 1100 NZST

    Communications Medicine

    Early use by over 13,000 participants, including 462 who were COVID-positive, found the tool was 79 per cent sensitive at detecting COVID, comparing well to RAT tests. ... on in the brain with Read more about Could a sniff test using smelly stuff at home pick up COVID-19?

    InternationalWeizmann Institute of Science, Bezalel Academy of Fine Arts and Design, Edith Wolfson Medical Center, Tel Aviv University (Israel), Karolinska Institutet and Stockholm University (Sweden), University of Oslo (Norway), University of Tokyo (Japan), Champalimaud Centre for the Unknown (Portugal), University of Florence (Italy)

  9. How do Delta and Omicron symptoms differ for vaccinated people?

    Publicly released: Fri 8 Apr 2022 at 0801 AEST, 1001 NZST

    The Lancet

    Between June 1, 2021, and Jan 17, 2022, the researchers identified 63 002 participants who tested positive for SARS-CoV-2 and reported symptoms in the ZOE app. ... The authors conclude: “We report that Read more about How do Delta and Omicron symptoms differ for vaccinated people?

    InternationalKing’s College London, UK

  10. Motivation - not only attitude - is key when it comes to vaccine decisions

    Publicly released: Fri 8 Apr 2022 at 0400 AEST, 0600 NZST

    PLOS ONE

    Kiwi and Australian researchers sought to understand - and predict - the motivation of individuals to be vaccinated against COVID-19, using a policy response framework. ... They say the results also Read more about Motivation - not only attitude - is key when it comes to vaccine decisions

    Australia; New Zealand; NSWManaaki Whenua - Landcare Research | The University of New England

  11. At-risk Kiwis show strong immune response to Pfizer vaccine

    Publicly released: Thu 7 Apr 2022 at 1200 AEST, 1400 NZST

    She says while the study showed no difference in the antibody immune response in Māori when compared to non-Māori, the rates of infection and hospitalisation from COVID-19 remain higher ... SARS-CoV-2 Read more about At-risk Kiwis show strong immune response to Pfizer vaccine

    New ZealandMalaghan Institute of Medical Research | University of Otago ...

  12. Serious blood clot risk for months after getting COVID-19

    Publicly released: Thu 7 Apr 2022 at 0830 AEST, 1030 NZST

    The BMJ

    Using national registries in Sweden, they identified more than one million people with confirmed SARSCoV-2 infection (the virus responsible for covid-19) between 1 February 2020 and 25 May 2021, Read more about Serious blood clot risk for months after getting COVID-19

    InternationalUmeå University (Sweden), The Open University (UK), University of Helsinki and Helsinki University Hospital (Finland)

  13. Fluvoxamine appears to be an effective option for reducing COVID-19 hospitalisations

    Publicly released: Thu 7 Apr 2022 at 0100 AEST, 0300 NZST

    JAMA Network Open

    Fluvoxamine, a drug usually used as an antidepressant, is highly likely to be able to reduce hospitalisations when used early as a COVID-19 treatment, according to an international meta-analysis. Read more about Fluvoxamine appears to be an effective option for reducing COVID-19 hospitalisations

    InternationalMcGill University Health Centre, Canada

  14. Meddle: the medical Wordle that’s boosting mental health

    Publicly released: Wed 6 Apr 2022 at 1100 AEST, 1300 NZST

    In conjunction with the new Meddle word game, the pair has also established a gofundme campaign to raise funds for COVID-19 vaccinations in developing countries. ... Infections are surging in vulnerable Read more about Meddle: the medical Wordle that’s boosting mental health

    Australia; SAUniversity of South Australia

  15. Super-spreader events may cement new COVID-19 variants

    Publicly released: Wed 6 Apr 2022 at 0901 AEST, 1101 NZST

    Journal of the Royal Society Interface

    Novel variants have prolonged the COVID-19 pandemic, leading to countless infections and deaths. ... Superspreading (one individual infecting many others) is a key feature of COVID-19 persistence. Read more about Super-spreader events may cement new COVID-19 variants

    InternationalFred Hutchinson Cancer Research Center, University of Washington, Seattle, US.

  16. Are our kits and puppers giving us superbugs?

    Publicly released: Wed 6 Apr 2022 at 0801 AEST, 1001 NZST

    European Congress of Clinical Microbiology & Infectious Diseases

    She continues, “Even before the COVID-19 pandemic, antibiotic resistance was one of the biggest threats to public health because it can make conditions like pneumonia, sepsis, urinary tract and Read more about Are our kits and puppers giving us superbugs?

    InternationalUniversity of Lisbon, Portugal

  17. Fourth Pfizer shot gave triple protection from severe COVID-19 in Israel

    Publicly released: Wed 6 Apr 2022 at 0700 AEST, 0900 NZST

    New England Journal of Medicine

    In a new study (abstract only) of over 1. 2 million older Israelis, people given a fourth dose had a 3. ... 5 times lower rate of severe COVID-19 illness in the fourth week afterwards than people with a Read more about Fourth Pfizer shot gave triple protection from severe COVID-19 in Israel

    InternationalWeizmann Institute of Science, Technion–Israel Institute of Technology, the Hebrew Universityof Jerusalem, Israel Ministry of Health, Gertner Institute for Epidemiology and Health Policy Research, Sheba Medical Center, Tel Aviv University (all Israel)

  18. How can we best allocate monoclonal antibodies to manage COVID-19?

    Publicly released: Wed 6 Apr 2022 at 0100 AEST, 0300 NZST

    JAMA Network Open

    status and either as treatment or as a preventative measure after COVID-19 exposure. ... The researchers say COVID-19 patients aged 60 years and older who are not fully vaccinated should be prioritised Read more about How can we best allocate monoclonal antibodies to manage COVID-19?

    InternationalNational University of Singapore, Singapore

  19. Nine in ten kids with prolonged COVID-19 symptoms less active, in survey of parents

    Publicly released: Tue 5 Apr 2022 at 1038 AEST, 1238 NZST

    Future Microbiology

    Researchers have surveyed parents of 510 children who had COVID-19 symptoms that lasted longer than four weeks. ... The authors highlight some important biases, especially that the survey was promoted by Read more about Nine in ten kids with prolonged COVID-19 symptoms less active, in survey of parents

    InternationalFondazione Policlinico Universitario A Gemelli Istituto di Ricovero e Cura a Carattere Scientifico, Dipartimento di Scienze Biotecnologiche di Base, Cliniche Intensivologiche e Perioperatorie, Universita Cattolica del Sacro Cuore, Global Health Research Institute, Istituto di Igiene, Universita Cattolica del Sacro Cuore (Italy), University College London, Imperial College London, Coventry University Group, Long Covid Kids (UK), Sechenov First Moscow State Medical University (Russia)University

  20. BACKGROUND BRIEFING: Influenza in times of COVID-19

    Publicly released: Tue 5 Apr 2022 at 1000 AEST, 1200 NZST

    As our healthcare system is under pressure from each new wave of COVID-19 infections, how will it fare with the pandemic and our upcoming flu season? ... vaccines for specific SARS-CoV-2 strains, similar Read more about BACKGROUND BRIEFING: Influenza in times of COVID-19

    Australia; NSW; VIC; QLDAustralian Science Media Centre | The Peter Doherty Institute for Infection and Immunity ...

Show Results

  1. 10
  2. 20
  3. 50